NCT00224276View on ClinicalTrials.gov

Prevalence of Diabetes Mellitus Among Patients Treated With Atypical and Conventional Antipsychotics

CompletedOBSERVATIONAL

Enrollment

100

Participants

Timeline

Start Date

Not specified

Conditions

SchizophreniaBipolar DisorderDiabetes Mellitus

All Listed Sponsors

collaborator

Janssen Pharmaceutica N.V., Belgium

INDUSTRY

lead

Yale University

OTHER

NCT00224276 - Prevalence of Diabetes Mellitus Among Patients Treated With Atypical and Conventional Antipsychotics | Biotech Hunter | Biotech Hunter